πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 389 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8030341

Dmt-derivative compounds and related compositions and methods of use

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8029788

Variants of humanized anti-carcinoma MAb CC49

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8017578

Orally active peptides that prevent cell damage and death

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8012490

Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8003764

Folliculin-specific antibodies and methods of detection

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7999077

IRTA2 antibodies and methods of use

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7998682

Method for assessing atherosclerosis by measuring expression of FOS or DUSP1 in monocytes

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7982011

Mutated anti-cd22 antibodies and immunoconjugates

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jul 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7964576

Anti-arthropod vector vaccines, methods of selecting and uses thereof

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7960356

Oligodeoxynucleotide and its use to induce an immune response

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7959934

Method for rapid generation of mature dendritic cells

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7959929

Materials and methods for respiratory disease control in canines

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7947289

Multimeric protein toxins to target cells having multiple identifying characteristics

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue May 24 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7943775

Small molecules for imaging protein-protein interactions

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7943318

Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7923535

Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Apr 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7915396

Nucleic acid molecules encoding minimally immunogenic variants of SDR-grafted humanized an

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7915040

Defensin-antigen fusion proteins

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7906292

Localization and characterization of flavivirus envelope glycoprotein cross-reactive epito

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7897152

Viral chemokine-antigen fusion proteins

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Mar 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7888070

Nucleic acids encoding growth hormone with a modified RSP sorting signal

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7863041

Rabies virus vector systems and compositions and methods thereof

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7807458

Multilineage-inducible cells and uses thereof

THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF VETERANS AFFAIRS Β· Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7803386

Poly-gamma-glutamic conjugates for eliciting immune responses directed against bacilli

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted